Erhalte eine Antwort von diesem Arbeitgeber
Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.
CSL Behring in Mechelen seeks an experienced Market Access professional to define and deliver reimbursement strategies for the Benelux region. You will design, develop and implement strategies for pricing, reimbursement and HTA positioning to maximize patient access and market uptake.
You will work cross-functionally with marketing, medical and regulatory teams to develop value propositions and communicate CSL Behring’s product value to payers and decision makers.
The incumbent develops and evaluates mutually beneficial programs to define and deliver market access. Designs, develops and implements effective strategies for one or more of the following: pricing and reimbursement, health technology, evidence-based medicine review and/or health economic modeling. Communicates the unique attributes of therapeutic area drugs to external stakeholders to ensure the drug's value proposition will be recognized and maximize market uptake. Works collectively with payers, including HTA, reimbursement influencers and other decision makers to ensure continuous changing reimbursement systems remain fair to all involved parties. He/she will support the company growth, through the best use of human capital and technical resources within the company and that activities are conducted in a manner consistent with: All short- and long-term business objectives The global commercial development strategies Corporate Policies, local “rules, laws and regulations” The values and ethical standard of CSL Behring.
This role is based in Mechelen and requires to be 3 days a week onsite.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging.
CSL is an Equal Opportunity Employer.
Equal Opportunity Employer CSL is an Equal Opportunity Employer.
If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please click here.
CSL Global Privacy Notice for Job Applicants and Candidates